SCS Success Prediction Calculator
Does the patient have a history of long-term opiate use
1
?
Select your option
No - 0
Yes - 1
Does the patient have a history of tumor without metastasis?
Select your option
No - 0
Yes - 1
Presence of polypharmacy
2
?
Select your option
No - 0
Yes - 1
Is the patient concurrently using benzodiazepines
3
?
Select your option
No - 0
Yes - 1
Which pre-dose group
4
is the patient part of?
Select your option
1
2
3
4
Prediction:
Enter Values Above
SCS success is defined as opioid dose stability or reduction one year after SCS.
1
Opioid usage for >90 days within the 1 year pre-SCS period.
2
Using more than 5 types of medications during the 3 month period prior to SCS trial.
3
At least 1 day of overlap between opioids and benzodiazepine prescriptions during the 3 month period before SCS trial.
4
Pre-Dose Groups are defined as according to
average daily milligram morphine equivalents (MME)
as follows: 1: ≤20, 2: 21-50, 3: 51-90, and 4: >90.
This algoirthm has been validated and published in
Neurosurgery
.